AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06638268 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acute TAVI
Description: TAVI must be performed as soon as possible and within 12 hours of admission to the heart center.
Study NCT06638268 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stabilization and subacute TAVI
Description: Patients are stabilized according to target parameters. Treatment may include vasopressor, mechanical ventilation, renal replacement therapy, and blood transfusion. TAVI is then performed no earlier than 72 hours of admission to heart center.
Study NCT06426719 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge wideninig via applying osseodensification protocol using densah burs
Description: alveolar ridge expansion using densah burs in horizontally deficient maxillary alveolar ridges prior to dental implants insertion
Study NCT06426719 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Alveolar ridge widening via hand osteotomes
Description: Alveolar ridge expansion using hand driven osteotomes in horizontally deficient maxillary alveolar ridges prior to dental Implant insertion
Study NCT05391451 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: efficacy of quadratus lumborum block in post-operative analgesia in kidney transplant surgery
Description: no premedication for anxiolytic purposes before surgery. Cimetidin 200mg can be administrated for Mendelson syndrome prevention. After general anesthesia induction, echo-guided quadratus lumborum block is performed by applying 20ml of levobupivacaine
Study NCT05391451 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: general anesthesia
Description: general anesthesia is the current technique for kidney transplant surgery. The protocol involves the combination of several drugs: Propofol, Remifentanil, Ketamin, Atracurium or Cisatracurium. Curarization monitoring is systematic.
Study NCT05519878 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Undergo routine treatment and usual follow up care
Study NCT05519878 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bright White Light Therapy
Description: Undergo bright white therapy
Study NCT05150405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QLF31907
Description: In this study, seven dose groups were proposed. The frequency of administration was once every two weeks, and four weeks was one therapeutic cycle. The subjects will receive six cycles of QLF31907 treatment at most.
Study NCT05790460 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telehealth
Description: Enhanced synchronous telehealth nurse navigation, compared to usual care nurse navigation, to increase timely molecularly-informed treatment recommendations through early integration of concurrent molecular testing.
Study NCT06599619 — intervention group
Intervention type: DRUG
Intervention: Nivolumab
Description: Nivolumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system.
Study NCT06599619 — intervention group
Intervention type: DRUG
Intervention: Pembrolizumab
Description: Pembrolizumab is a monoclonal antibody and a type of immune checkpoint inhibitor that's used in cancer immunotherapy. It works by attaching to the PD-1 protein on the surface of T cells, which are immune cells. This prevents cancer cells from suppressing the immune system, allowing the immune system to attack and kill the cancer cells.
Study NCT05519878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupational Therapy
Description: Undergo occupational therapy
Study NCT06256939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapy BRIDGE Program
Description: A standardized education and coaching intervention will be developed to promote optimal neurodevelopmental outcomes through caregiver empowerment. This pilot study will enroll up to 15 infants with IVH and their caregivers during their NICU stay. These infant-caregiver dyads will receive up to 10 sessions utilizing the Therapy BRIDGE program over a four-month period that spans the hospital to home transition.
Study NCT05519878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT05519878 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT05409183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CRD-740
Description: Tablets administered orally.
Study NCT05409183 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets administered orally.
Study NCT05776381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shared Decision Making using a Patient Decision Aid.
Description: The intervention comprises the surgeon actively using the tailored PtDA and SDM with the patient when deciding on the management of an unexpected malignant colorectal polyp.
Study NCT06645028 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive treatment programme
Description: Intervention Group: 8-day intensive treatment where each treatment day consists of the following schedule:~Physical activity: 30 minutes Prolonged Exposure (PE): 90 minutes Physical activity: 30 minutes Lunch Physical activity: 60 minutes Eye Movement Desensitization and Reprocessing (EMDR): 90 minutes Physical activity: 30 minutes (omitted on days 4 and 8) Dinner Psychoeducation (omitted on days 4 and 8) Participants stay at the SÄS patient hotel during the treatment (with a three-day weekend break between treatment days 1-4 and 5-8). The treatment concept includes therapist rotation, meaning that participants switch therapists between PE and EMDR sessions. The purpose of this is to increase focus on the processing process rather than the relationship between the therapist and the client.
Study NCT06645028 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: Control group: 16 treatment sessions (90 minutes in duration) either Eye movement desensitisation and reprocessing (EMDR) or Prolonged Exposure (PE) in a standard outpatient format-weekly sessions. Participants can choose to attend 6 sessions of Psychoeducation for PTSD in a group format before starting EMDR or PE.
Study NCT05212337 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Denosumab
Description: Subcutaneous injection with 60 mg Denosumab once
Study NCT05212337 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium chloride
Description: Subcutaneous injection with NaCl once
Study NCT06603012 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GET Up PD
Description: * The exercise training prescription involves performing 3 days per week and include (a) aerobic exercise: 30+ minutes of moderate-intensity walking (≥100 steps/min) monitored by a waist-worn pedometer, and (b) resistance training: 1-3 sets, 8-12 repetitions of 5-10 exercises targeting lower and upper body, and core muscle groups using elastic bands.~* Other components of the GET Up PD program include appropriate exercise equipment (pedometer, resistance bands), one-on-one coaching sessions via Zoom, action-planning via calendars, logbooks for self-monitoring, and SCT-based newsletters.
Study NCT06603012 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stretching and Flexibility
Description: * The training will involve the same frequency, duration, timeline, behavior change content, and interactions with behavioral coach as the GET Up PD program, and account for activity, social-contact, and attention.~* Other components of the Stretching and Flexibility program include appropriate exercise equipment (yoga mat), one-on-one coaching sessions via Zoom, calendars, logbooks and newsletters similar to the GET Up PD program.
Study NCT05185115 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxygen
Description: administration of oxygen at a flow rate of 3 liters per minute, via nasal cannula throughout the hospitalization.
Study NCT06569433 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: THERAPEUTIC EXERCISE AND MOBILISATION OF THE FEMORAL NERVE
Description: the control group that will perform only therapeutic exercise will perform a specific exercise programme for knee tendinitis under the supervision of a physiotherapist, while the intervention group that will perform therapeutic exercise plus femoral nerve mobilisation will receive therapeutic exercise sessions and femoral nerve mobilisations performed by a trained physiotherapist.~The intervention will last for 6 weeks, during which 60-minute sessions will be held at the centre, measurements will be taken during the six weeks, using standardised questionnaires to evaluate the variables (set out below) and always measuring the range of movement and femoral nerve mobility with the Slump Test on the same day of the week and at the same time of treatment.
Study NCT05248009 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Semi-Permanent Tattoo Ink
Description: Subjects will receive semi-permanent tattoo ink in place of the permanent ink utilized in the standard of care. Subjects will be monitored during their treatment course and for 15 months following treatment completion.
Study NCT05185115 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no oxygen therapy
Description: No oxygen therapy during hospitalization
Study NCT06183593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiofrequency application
Description: Radiofrequency stimuli will be applied at pain threshold intensity. Arm and leg will be stimulated.
Study NCT06183593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pinprick stimuli
Description: Pinprick stimuli will be administered at varying speeds and forces using an automated device
Study NCT05751811 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: The immersive video simulated a magical journey through a calming starry sky on a flying carpet. The headset will play the immersive video content throughout the hysteroscopic procedure; and will stop playing the content as the procedure comes to an end. Participant can adjust the volume of the sound according to her comfort.~The duration of hysteroscopic operation will be 5 to 20 minutes.
Study NCT06076642 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TAK-881
Description: Participants will receive SC infusion of TAK-881.
Study NCT06076642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SC Investigational Needle Sets
Description: The single-use only SC needle set will be used to administer TAK-881 to the target depth below the skin surface. One needle set (single or bifurcated) will be used per infusion.
Study NCT06495866 — intervention group
Intervention type: RADIATION
Intervention: ultrasound
Description: Ultrasound finding of entheseal sites of upper \& lower limbs of all groups and scoring according to enthesitis scoring system
Study NCT05219123 — intervention group
Intervention type: OTHER
Intervention: ERCP with no PD cannulation
Description: ERCP with no PD cannulation
Study NCT05219123 — intervention group
Intervention type: OTHER
Intervention: ERCP with single PD cannulation
Description: ERCP with single PD cannulation
Study NCT04570722 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Ipsilateral peripheral IV insertion
Description: Patients with successful ipsilateral intravenous access will be provided a patient education sheet describing signs and symptoms that should be reported to the study team. All participants will be contacted by the study team at twelve week intervals for 12 months after their radiology encounter for completion of symptom assessments. If a subject reports new signs or symptoms of lymphedema during follow-up, a clinic appointment for volumetric measurements and thorough evaluation will occur
Study NCT05751811 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Relaxing and light music will play throughout the hysteroscopic procedure; and will stop playing as the procedure comes to an end. Participant can adjust the volume of the sound according to her comfort.~The duration of hysteroscopic operation will be 5 to 20 minutes.
Study NCT06078189 — intervention group
Intervention type: DEVICE
Intervention: HORUS
Description: The trapezium-metacarpal arthroplasty consists of the installation of a bipolar prosthesis composed of a metacarpal implant and a trapezial implant articulated through a metacarpal head.
Study NCT06520553 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1569912 (C-14)
Description: unlabelled BI 1569912 mixed with \[14C\]- labelled BI 1569912
Study NCT06520553 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1569912 (C-13)
Description: \[13C\]- labelled BI 1569912
Study NCT06679478 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS) Early Mobilization Protocol
Description: The intervention is applied from the first day after surgery until discharge. (including the day of discharge).
Study NCT06675266 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Development of AI algorithm for early detection of fetal brain anomalies in the second trimester screening scan
Description: Development of AI algorithm for early detection of fetal brain anomalies in the second trimester of pregnancy
Study NCT04305548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trabectedin
Description: Treatment with trabectedin: 1.5 mg/m² - 1.3 mg/m² (at investigator's discretion, with a top-dose of 2.6 total mg per cycle), given in 24-hour continuous infusion
Study NCT05764863 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: fMRI
Description: The participant will then complete a series of working memory tasks under three distinct conditions as described above (visual spatial, visual non-spatial, auditory). The instructions and tasks will be administered via an MRI compatible monitor and headset system (NordicNeuroLab). During the tasks, the participant's brain activity will be recorded. Finally, at the end of the experiment, a high-resolution anatomical image of the brain will be acquired in order to facilitate the subsequent data processing steps and to define the position of the interparietal sulcus for each subject. The visit will be completed by a visual imaging questionnaire.
Study NCT05878899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Description: Prophylactic dose of enoxaparin once daily for 10 days after delivery.
Study NCT06204939 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Randomizing for EPGB procedure
Description: Classic gastric bypass with 2 anastomoses but with an extended pouch of 12-15cm and a biliary limb of 150cm.~Patients will be single blinded randomized for one of the two procedures. 125 patients will undergo EPGB and 125 patients will undergo OAGB.~Pre-operatively, 6 months post-op and yearly post-op we will collect: weight, complications, revisions, comorbidities, blood samples and questionnaires.
Study NCT06204939 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Randomizing for OAGB procedure
Description: Gastric bypass with 1 anastomosis and an extended pouch of 12-15cm and a biliary limb of 150cm.~Patients will be single blinded randomized for one of the two procedures. 125 patients will undergo EPGB and 125 patients will undergo OAGB.~Pre-operatively, 6 months post-op and yearly post-op we will collect: weight, complications, revisions, comorbidities, blood samples and questionnaires.
Study NCT06674057 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: KinesioTaping
Description: The experimental group will receive the following treatment for week 1-3 (3 days on alternate days):~* Passive and active ROMs 25 repetitions each, 3 times per week.~* PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week.~* D1 flexion and extension for 20 repetitions 3 times per week.~* Kinesio tape 3 times per week. (Anchor opposed to effected compartment to provide facilitation and sustained stretch).~For week 3-6 the treatment will include:~* Passive and active ROMs 25 repetitions each, 3 times per week.~* PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week.~* D1 flexion and extension for 20 repetitions 3 times per week.~* Strengthening affected muscle groups by resistance training, 3 times per week (using a resistance band of mediu
Study NCT06674057 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control group will receive the following treatment for week 1-3 on alternate days:~* Passive and active ROMs 25 repetitions each, 3 times per week.~* PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week.~* D1 flexion and extension for 20 repetitions 3 times per week.~For week 3-6 the treatment will include:~* Passive and active ROMs 25 repetitions each, 3 times per week.~* PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week.~* D1 flexion and extension for 20 repetitions 3 times per week.~* Strengthening affected muscle groups by resistance training, 3 times per week (using a resistance band of medium resistance).
Study NCT06674941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teprotumumab
Description: Administered as an SC injection.
Study NCT06675838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time Management and Procrastination Behavior Management Training
Description: Intervention Content~Training Program Name: Time Management and Procrastination Behavior Management Training Duration: 3 sessions of 1 hour each, 5-day program Target Audience: Intern Nurses~Training Content:~Fundamentals of Time Management:~Definition and importance of time management. Key principles for effective use of time (prioritization, time blocking, planning).~Understanding Procrastination Behavior:~Definition and reasons for procrastination behavior. Effects of procrastination on student success.~Time Management Strategies:~Task Prioritization: Differentiating between urgent and important tasks. Time Blocking: Completing specific tasks in designated time slots. Daily Planning: Organizing daily tasks and activities.~Managing Procrastination Behavior:~Identification and analysis of procrastination habits. Coping strategies for procrastination (e.g., goal setting, increasing motivation, self-rewarding).~Effective Teaching Techniques:~Presentations and Information Sharing
Study NCT06681558 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Group Nasal Cannula
Description: Oxygen administered during the endoscopic retrograde cholangiopancreatography (ERCP) procedure will be delivered through a conventional oxygen mask.~The nasal cannula is a device that provides oxygen to patients through the nasal passages.
Study NCT06681558 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Group Procedural Oxygen Mask
Description: Oxygen administered during the endoscopic retrograde cholangiopancreatography (ERCP) procedure will be delivered through a Procedural Oxygen Mask (POM® ELITE MF). The procedural oxygen mask is a device that covers both the mouth and nose to deliver oxygen to the patient. Its reservoir feature increases the concentration of delivered oxygen
Study NCT06673589 — intervention group
Intervention type: BEHAVIORAL
Intervention: Transcendental Meditation
Description: meditation practice
Study NCT06674291 — intervention group
Intervention type: DRUG
Intervention: No intervention (observational study)
Description: This is an observational registry conducted in the real world clinical setting and there is no intervention in this study. Treatment of MDR-END Regimen and the follow-up of subjects will be conducted in the clinical judgment of the investigator.
Study NCT06675773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conscious Awareness Development Psychoeducation Program
Description: The Conscious Awareness Development Psychoeducation Program consists of nine sessions. The sessions will be applied once a week and last 90 minutes. The psychoeducation program is prepared based on conscious awareness. Conscious awareness and self-compassion techniques will be used in the sessions. Homework will be given to the participants in each session.
Study NCT06678581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAP-001
Description: Solid Oral Tablet
Study NCT06678581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Solid Oral Tablet
Study NCT06679543 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation
Description: Participants will be asked to come to the lab for testing after a night of partial sleep deprivation. Participants will be asked to fall asleep at their habitual bedtime but wake up early (\~40% of normal sleep duration).
Study NCT06685016 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Evaluation of Dentin hypersensitivity with VAS scale
Description: Dentin hypersensitivity and periodontal indices evaluation are performed after and before IPR, at 1 week, 1 month and 3 months
Study NCT06690723 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin (Forxiga)
Description: Dapagliflozin plus lifestyle modification
Study NCT06690723 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 ( Colecalciferol)
Description: Vitamin D3 plus lifestyle modification
Study NCT03149211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UB-421
Description: Subjects will receive 13 doses of the UB-421 by intravenous infusion at 25 mg/kg bi-weekly (Cohort 2, 26 weeks).
Study NCT03149211 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: current standard HAART treatment
Description: Subjects will receive current standard HAART treatment as the active control group.